Despite Detrimental Side Effects of Adderall, FDA Advises Not to Stop Giving the Drug to Patients

.

Despite Detrimental Side Effects of Adderall, FDA Advises Not to Stop Giving the

Adderall is a medicine that is prescribed for treatment of attention deficit hyperactivity disorder or ADHD.

According to the medication guide for Adderall XR, the medicine has detrimental side effects. These include heart related troubles such as sudden death in patients, who have heart problems or heart defects. It can also result in heart attacks and strokes in adults, an increase in blood pressure and heart rate.

Besides these physical side effects the medication also has an adverse impact on mental health. It can lead to worsening of behavior, problems in thinking, augment bipolar disorder or cause the disease, aggressive behavior in all patients.

In children and in teenagers, the medicine is linked with fresh psychotic symptoms such as hearing voices, believing in things that are untrue and suspicious or maniacal signs.

The Food and Drug Administration has issued a notice regarding the injurious side effects of stimulant medicines such as Adderall on cardiovascular health. The alert was issued on June 23, 2009.

The FDA also undertook a study on the impact of the drug on children. The primer data suggests that Adderall augment the risk of sudden deaths in this group.

However, the agency was not certain whether the drug lead to death in these cases. It has therefore stated that patients should not stop taking the medicines.


Latest News

DoubleLine Capital Sold Off All its European Equities Holdings following a Huge
Qualcomm Files Complaint against Meizu with Beijing Authorities over Intellectua
Barnes & Noble Broadening its Business Model Venturing into a Beer and Wine Stor
Will Result of the Brexit Vote Reflect in the U.S. Presidential Elections? A Que
Report Shows Large Number of Americans still Prefer Receiving Credit Card Statem
U.S. Big Banks Pass Annual Stress Test
Viacom’s Board will Remain as it is for the Time being, Judge Sets Hearing for J
Crude Stockpiles Drop in the U. S
A New Study Highlights that U. S. Expected to Spend $2.6 Trillion Less than Esti
SolarCity Shares Soar with Tesla's Bid for the Company
The Leave as well as Remain Camps Gathers Pace in Brexit
Oil’s Advance Halts as Market Awaits U.S Stock Pile Data and Brexit Poll